Global Afatinib Tablets Market Growth (Status and Outlook) 2026-2032

June 2026 | 95 pages | ID: G258A0204D3AEN
LP Information

Abstracts

The global Afatinib Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Afatinib Tablets is an oral targeted drug used to treat certain types of non-small cell lung cancer (NSCLC) and belongs to the tyrosine kinase inhibitor (TKI) class of drugs.

United States market for Afatinib Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Afatinib Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Afatinib Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Afatinib Tablets players cover Pfizer Inc., Teva Takeda Yakuhin Ltd., LTL Pharma Co., Ltd., Mylan Pharmaceuticals, Organon LLC, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the ?Afatinib Tablets Industry Forecast? looks at past sales and reviews total world Afatinib Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Afatinib Tablets sales for 2026 through 2032. With Afatinib Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Afatinib Tablets industry.

This Insight Report provides a comprehensive analysis of the global Afatinib Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Afatinib Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Afatinib Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Afatinib Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Afatinib Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Afatinib Tablets market by product type, application, key players and key regions and countries.

Segmentation by Type:

• 50mg
• 100mg
• 200mg

Segmentation by Application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer Inc.
• Teva Takeda Yakuhin Ltd.
• LTL Pharma Co., Ltd.
• Mylan Pharmaceuticals
• Organon LLC
• Teva Pharmaceutical Industries
• Merck Europe B.V.
• Santen Pharmaceutical Co.,Ltd.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Afatinib Tablets Market Size (2021-2032)
  2.1.2 Afatinib Tablets Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Afatinib Tablets by Country/Region (2021, 2025 & 2032)
2.2 Afatinib Tablets Segment by Type
  2.2.1 50mg
  2.2.2 100mg
  2.2.3 200mg
  2.2.4 Afatinib Tablets Market Size by Type
    2.2.4.1 Afatinib Tablets Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.4.2 Global Afatinib Tablets Market Size Market Share by Type (2021-2026)
2.3 Afatinib Tablets Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Others
  2.3.4 Afatinib Tablets Market Size by Application
    2.3.4.1 Afatinib Tablets Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Afatinib Tablets Market Size Market Share by Application (2021-2026)

3 AFATINIB TABLETS MARKET SIZE BY PLAYER

3.1 Afatinib Tablets Market Size Market Share by Player
  3.1.1 Global Afatinib Tablets Revenue by Player (2021-2026)
  3.1.2 Global Afatinib Tablets Revenue Market Share by Player (2021-2026)
3.2 Global Afatinib Tablets Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 AFATINIB TABLETS BY REGION

4.1 Afatinib Tablets Market Size by Region (2021-2026)
4.2 Global Afatinib Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Afatinib Tablets Market Size Growth (2021-2026)
4.4 APAC Afatinib Tablets Market Size Growth (2021-2026)
4.5 Europe Afatinib Tablets Market Size Growth (2021-2026)
4.6 Middle East & Africa Afatinib Tablets Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Afatinib Tablets Market Size by Country (2021-2026)
5.2 Americas Afatinib Tablets Market Size by Type (2021-2026)
5.3 Americas Afatinib Tablets Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Afatinib Tablets Market Size by Region (2021-2026)
6.2 APAC Afatinib Tablets Market Size by Type (2021-2026)
6.3 APAC Afatinib Tablets Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Afatinib Tablets Market Size by Country (2021-2026)
7.2 Europe Afatinib Tablets Market Size by Type (2021-2026)
7.3 Europe Afatinib Tablets Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Afatinib Tablets by Region (2021-2026)
8.2 Middle East & Africa Afatinib Tablets Market Size by Type (2021-2026)
8.3 Middle East & Africa Afatinib Tablets Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL AFATINIB TABLETS MARKET FORECAST

10.1 Global Afatinib Tablets Forecast by Region (2027-2032)
  10.1.1 Global Afatinib Tablets Forecast by Region (2027-2032)
  10.1.2 Americas Afatinib Tablets Forecast
  10.1.3 APAC Afatinib Tablets Forecast
  10.1.4 Europe Afatinib Tablets Forecast
  10.1.5 Middle East & Africa Afatinib Tablets Forecast
10.2 Americas Afatinib Tablets Forecast by Country (2027-2032)
  10.2.1 United States Market Afatinib Tablets Forecast
  10.2.2 Canada Market Afatinib Tablets Forecast
  10.2.3 Mexico Market Afatinib Tablets Forecast
  10.2.4 Brazil Market Afatinib Tablets Forecast
10.3 APAC Afatinib Tablets Forecast by Region (2027-2032)
  10.3.1 China Afatinib Tablets Market Forecast
  10.3.2 Japan Market Afatinib Tablets Forecast
  10.3.3 Korea Market Afatinib Tablets Forecast
  10.3.4 Southeast Asia Market Afatinib Tablets Forecast
  10.3.5 India Market Afatinib Tablets Forecast
  10.3.6 Australia Market Afatinib Tablets Forecast
10.4 Europe Afatinib Tablets Forecast by Country (2027-2032)
  10.4.1 Germany Market Afatinib Tablets Forecast
  10.4.2 France Market Afatinib Tablets Forecast
  10.4.3 UK Market Afatinib Tablets Forecast
  10.4.4 Italy Market Afatinib Tablets Forecast
  10.4.5 Russia Market Afatinib Tablets Forecast
10.5 Middle East & Africa Afatinib Tablets Forecast by Region (2027-2032)
  10.5.1 Egypt Market Afatinib Tablets Forecast
  10.5.2 South Africa Market Afatinib Tablets Forecast
  10.5.3 Israel Market Afatinib Tablets Forecast
  10.5.4 Turkey Market Afatinib Tablets Forecast
10.6 Global Afatinib Tablets Forecast by Type (2027-2032)
10.7 Global Afatinib Tablets Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Afatinib Tablets Forecast

11 KEY PLAYERS ANALYSIS

11.1 Pfizer Inc.
  11.1.1 Pfizer Inc. Company Information
  11.1.2 Pfizer Inc. Afatinib Tablets Product Offered
  11.1.3 Pfizer Inc. Afatinib Tablets Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Pfizer Inc. Main Business Overview
  11.1.5 Pfizer Inc. Latest Developments
11.2 Teva Takeda Yakuhin Ltd.
  11.2.1 Teva Takeda Yakuhin Ltd. Company Information
  11.2.2 Teva Takeda Yakuhin Ltd. Afatinib Tablets Product Offered
  11.2.3 Teva Takeda Yakuhin Ltd. Afatinib Tablets Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Teva Takeda Yakuhin Ltd. Main Business Overview
  11.2.5 Teva Takeda Yakuhin Ltd. Latest Developments
11.3 LTL Pharma Co., Ltd.
  11.3.1 LTL Pharma Co., Ltd. Company Information
  11.3.2 LTL Pharma Co., Ltd. Afatinib Tablets Product Offered
  11.3.3 LTL Pharma Co., Ltd. Afatinib Tablets Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 LTL Pharma Co., Ltd. Main Business Overview
  11.3.5 LTL Pharma Co., Ltd. Latest Developments
11.4 Mylan Pharmaceuticals
  11.4.1 Mylan Pharmaceuticals Company Information
  11.4.2 Mylan Pharmaceuticals Afatinib Tablets Product Offered
  11.4.3 Mylan Pharmaceuticals Afatinib Tablets Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Mylan Pharmaceuticals Main Business Overview
  11.4.5 Mylan Pharmaceuticals Latest Developments
11.5 Organon LLC
  11.5.1 Organon LLC Company Information
  11.5.2 Organon LLC Afatinib Tablets Product Offered
  11.5.3 Organon LLC Afatinib Tablets Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Organon LLC Main Business Overview
  11.5.5 Organon LLC Latest Developments
11.6 Teva Pharmaceutical Industries
  11.6.1 Teva Pharmaceutical Industries Company Information
  11.6.2 Teva Pharmaceutical Industries Afatinib Tablets Product Offered
  11.6.3 Teva Pharmaceutical Industries Afatinib Tablets Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Teva Pharmaceutical Industries Main Business Overview
  11.6.5 Teva Pharmaceutical Industries Latest Developments
11.7 Merck Europe B.V.
  11.7.1 Merck Europe B.V. Company Information
  11.7.2 Merck Europe B.V. Afatinib Tablets Product Offered
  11.7.3 Merck Europe B.V. Afatinib Tablets Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Merck Europe B.V. Main Business Overview
  11.7.5 Merck Europe B.V. Latest Developments
11.8 Santen Pharmaceutical Co.,Ltd.
  11.8.1 Santen Pharmaceutical Co.,Ltd. Company Information
  11.8.2 Santen Pharmaceutical Co.,Ltd. Afatinib Tablets Product Offered
  11.8.3 Santen Pharmaceutical Co.,Ltd. Afatinib Tablets Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Santen Pharmaceutical Co.,Ltd. Main Business Overview
  11.8.5 Santen Pharmaceutical Co.,Ltd. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. AfatinibTablets Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. AfatinibTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 50mg
Table 4. Major Players of 100mg
Table 5. Major Players of 200mg
Table 6. AfatinibTablets Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global AfatinibTablets Market Size by Type (2021-2026) & ($ millions)
Table 8. Global AfatinibTablets Market Size Market Share by Type (2021-2026)
Table 9. AfatinibTablets Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global AfatinibTablets Market Size by Application (2021-2026) & ($ millions)
Table 11. Global AfatinibTablets Market Size Market Share by Application (2021-2026)
Table 12. Global AfatinibTablets Revenue by Player (2021-2026) & ($ millions)
Table 13. Global AfatinibTablets Revenue Market Share by Player (2021-2026)
Table 14. AfatinibTablets Key Players Head office and Products Offered
Table 15. AfatinibTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global AfatinibTablets Market Size by Region (2021-2026) & ($ millions)
Table 19. Global AfatinibTablets Market Size Market Share by Region (2021-2026)
Table 20. Global AfatinibTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global AfatinibTablets Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas AfatinibTablets Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas AfatinibTablets Market Size Market Share by Country (2021-2026)
Table 24. Americas AfatinibTablets Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas AfatinibTablets Market Size Market Share by Type (2021-2026)
Table 26. Americas AfatinibTablets Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas AfatinibTablets Market Size Market Share by Application (2021-2026)
Table 28. APAC AfatinibTablets Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC AfatinibTablets Market Size Market Share by Region (2021-2026)
Table 30. APAC AfatinibTablets Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC AfatinibTablets Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe AfatinibTablets Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe AfatinibTablets Market Size Market Share by Country (2021-2026)
Table 34. Europe AfatinibTablets Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe AfatinibTablets Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa AfatinibTablets Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa AfatinibTablets Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa AfatinibTablets Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of AfatinibTablets
Table 40. Key Market Challenges & Risks of AfatinibTablets
Table 41. Key Industry Trends of AfatinibTablets
Table 42. Global AfatinibTablets Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global AfatinibTablets Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global AfatinibTablets Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global AfatinibTablets Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Pfizer Inc. Details, Company Type, AfatinibTablets Area Served and Its Competitors
Table 47. Pfizer Inc. AfatinibTablets Product Offered
Table 48. Pfizer Inc. AfatinibTablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Pfizer Inc. Main Business
Table 50. Pfizer Inc. Latest Developments
Table 51. Teva Takeda Yakuhin Ltd. Details, Company Type, AfatinibTablets Area Served and Its Competitors
Table 52. Teva Takeda Yakuhin Ltd. AfatinibTablets Product Offered
Table 53. Teva Takeda Yakuhin Ltd. AfatinibTablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Teva Takeda Yakuhin Ltd. Main Business
Table 55. Teva Takeda Yakuhin Ltd. Latest Developments
Table 56. LTL Pharma Co., Ltd. Details, Company Type, AfatinibTablets Area Served and Its Competitors
Table 57. LTL Pharma Co., Ltd. AfatinibTablets Product Offered
Table 58. LTL Pharma Co., Ltd. AfatinibTablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. LTL Pharma Co., Ltd. Main Business
Table 60. LTL Pharma Co., Ltd. Latest Developments
Table 61. Mylan Pharmaceuticals Details, Company Type, AfatinibTablets Area Served and Its Competitors
Table 62. Mylan Pharmaceuticals AfatinibTablets Product Offered
Table 63. Mylan Pharmaceuticals AfatinibTablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Mylan Pharmaceuticals Main Business
Table 65. Mylan Pharmaceuticals Latest Developments
Table 66. Organon LLC Details, Company Type, AfatinibTablets Area Served and Its Competitors
Table 67. Organon LLC AfatinibTablets Product Offered
Table 68. Organon LLC AfatinibTablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Organon LLC Main Business
Table 70. Organon LLC Latest Developments
Table 71. Teva Pharmaceutical Industries Details, Company Type, AfatinibTablets Area Served and Its Competitors
Table 72. Teva Pharmaceutical Industries AfatinibTablets Product Offered
Table 73. Teva Pharmaceutical Industries AfatinibTablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Teva Pharmaceutical Industries Main Business
Table 75. Teva Pharmaceutical Industries Latest Developments
Table 76. Merck Europe B.V. Details, Company Type, AfatinibTablets Area Served and Its Competitors
Table 77. Merck Europe B.V. AfatinibTablets Product Offered
Table 78. Merck Europe B.V. AfatinibTablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Merck Europe B.V. Main Business
Table 80. Merck Europe B.V. Latest Developments
Table 81. Santen Pharmaceutical Co.,Ltd. Details, Company Type, AfatinibTablets Area Served and Its Competitors
Table 82. Santen Pharmaceutical Co.,Ltd. AfatinibTablets Product Offered
Table 83. Santen Pharmaceutical Co.,Ltd. AfatinibTablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Santen Pharmaceutical Co.,Ltd. Main Business
Table 85. Santen Pharmaceutical Co.,Ltd. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. AfatinibTablets Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AfatinibTablets Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. AfatinibTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. AfatinibTablets Sales Market Share by Country/Region (2025)
Figure 8. AfatinibTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global AfatinibTablets Market Size Market Share by Type in 2025
Figure 10. AfatinibTablets in Hospital
Figure 11. Global AfatinibTablets Market: Hospital (2021-2026) & ($ millions)
Figure 12. AfatinibTablets in Clinic
Figure 13. Global AfatinibTablets Market: Clinic (2021-2026) & ($ millions)
Figure 14. AfatinibTablets in Others
Figure 15. Global AfatinibTablets Market: Others (2021-2026) & ($ millions)
Figure 16. Global AfatinibTablets Market Size Market Share by Application in 2025
Figure 17. Global AfatinibTablets Revenue Market Share by Player in 2025
Figure 18. Global AfatinibTablets Market Size Market Share by Region (2021-2026)
Figure 19. Americas AfatinibTablets Market Size 2021-2026 ($ millions)
Figure 20. APAC AfatinibTablets Market Size 2021-2026 ($ millions)
Figure 21. Europe AfatinibTablets Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa AfatinibTablets Market Size 2021-2026 ($ millions)
Figure 23. Americas AfatinibTablets Value Market Share by Country in 2025
Figure 24. United States AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC AfatinibTablets Market Size Market Share by Region in 2025
Figure 29. APAC AfatinibTablets Market Size Market Share by Type (2021-2026)
Figure 30. APAC AfatinibTablets Market Size Market Share by Application (2021-2026)
Figure 31. China AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 35. India AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe AfatinibTablets Market Size Market Share by Country in 2025
Figure 38. Europe AfatinibTablets Market Size Market Share by Type (2021-2026)
Figure 39. Europe AfatinibTablets Market Size Market Share by Application (2021-2026)
Figure 40. Germany AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 41. France AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 42. UK AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa AfatinibTablets Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa AfatinibTablets Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa AfatinibTablets Market Size Market Share by Application (2021-2026)
Figure 48. Egypt AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries AfatinibTablets Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 54. APAC AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 55. Europe AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 57. United States AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 58. Canada AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 59. Mexico AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 60. Brazil AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 61. China AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 62. Japan AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 63. Korea AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 65. India AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 66. Australia AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 67. Germany AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 68. France AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 69. UK AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 70. Italy AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 71. Russia AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 72. Egypt AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 73. South Africa AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 74. Israel AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 75. Turkey AfatinibTablets Market Size 2027-2032 ($ millions)
Figure 76. Global AfatinibTablets Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global AfatinibTablets Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries AfatinibTablets Market Size 2027-2032 ($ millions)